Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Therapeutic goods regulation (32)
- Regulatory compliance (15)
- Prescription medicines (11)
- Safety (8)
- In Vitro Diagnostic medical devices (IVDs) (7)
- Manufacturing (5)
- Medicine safety (5)
- Vaping hub (5)
- Clinical trials (4)
- Legislation (4)
- Over the counter (OTC) medicines (3)
- Unique Device Identification (UDI) hub (3)
- Complementary medicines (2)
- Compliance and enforcement hub (2)
- Medical devices safety (2)
- Shortages (2)
- Advanced therapies (1)
- Advertising (1)
- Alert/Advisory (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Blood and blood components (1)
- Cosmetics (1)
- COVID-19 vaccines (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Pharmacovigilance (1)
- Scheduling (national classification system) (1)
- TGA conformity assessment certification (1)
Search
116 result(s) found, displaying 1 to 25
-
PresentationsAn overview of the amended sponsor portal to include unapproved medical devices and provides guidance on how to apply for consent to import, supply or export medical devices that do not comply with the Essential Principles (EPs).
-
PresentationsGuidance on completing updated notification form for new therapeutic vaping products, and information on the re-statement of compliance when requested by TGA.
-
PresentationsSee the upcoming changes in the PRAC – the new procedure document that will replace the Uniform Recalls Procedure for Therapeutic Goods (URPTG).
-
PresentationsPresentations given by the TGA at the ARCS 2025 Regulatory Summit, 19 February 2025
-
PresentationsPresentation given at the 2024 ACTA Symposium, in Melbourne
-
PresentationsPresentations given by the TGA at the GMP Forum 19-20 November, Melbourne Convention and Exhibition Centre.
-
PresentationsChanges to applicable product standards for unapproved therapeutic vaping goods in 2025
-
PresentationsHear about the options we currently considering in relation to the future regulation of assistive technologies. Q and A session included.
-
PresentationsThis webinar provides information about the TGA’s public consultation paper on the proposed changes to the Australian Essential Principles and an opportunity to ask questions.
-
PresentationsAbout the changes to the compounding of glucagon-like peptide-1 receptor agonist (GLP-1 RA) products and how these changes will impact pharmacists, doctors and consumers.
-
PresentationsWebinar Tuesday 20 and Wednesday 21 August 2024
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
-
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
-
PresentationsPresentations given by the TGA at the 2024 ARCS Annual Conference, 12-14 June 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
-
-